Last reviewed · How we verify

NCT03593135

Effect of Apple Cider Vinegar in Type 2 Diabetics

Completed NA Last updated 19 July 2018
What this trial tests

NA trial testing Apple Cider Vinegar and tablet Tagipmet (Metformin + Sitagliptin group) in Randomized Controlled Trial in 126 participants. Completed in 14 November 2017.

Timeline
15 July 2017
Primary endpoint
14 November 2017
14 November 2017

Quick facts

Lead sponsorSheikh Zayed Federal Postgraduate Medical Institute
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment126
Start date15 July 2017
Primary completion14 November 2017
Estimated completion14 November 2017
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Sheikh Zayed Federal Postgraduate Medical Institute

Who can join

Adults 30 to 60, any sex, with Randomized Controlled Trial or Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: apple cider vinegar is natural traditional health beneficial nutraceutical used for many aliments. Diabetes mellitus (DM) has been considered a globally major health problem and posing health burden on families and health system. Diabetes is associated with life style that leading to reduce physical activities and increased in obesity. For development of diabetes the known mechanism are endocrine disorders which cause impaired insulin secretion, hepatic glucose over production and insulin resistance. Objective: The aim of current randomized controlled trial was to investigate the effect of apple cider vinegar on glycemic control and biochemical parameters in type 2 diabetic patients with poor glycaemic control. Material \& Methods: 110 type 2 diabetic patients according to inclusion criteria were selected and divided into two groups. Interventional group was given 15 ml apple cider vinegar in 200ml water during meal at night time for 3 months. Before and after HbA1C, fasting lipid profile, fasting blood sugar, anthropometrics and dietary changes were assessed and analyzed using IBM SPSS version 20 through paired sample T-test where needed. .

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Use of Nutraceuticals in Angiogenesis-Dependent Disorders.
    Morbidelli L, Terzuoli E, Donnini S. · · 2018 · cited 10× · PMID 30340320 · DOI 10.3390/molecules23102676

Verify or expand the search:

Other recruiting trials for Randomized Controlled Trial

Currently open trials in the same condition.

Other Sheikh Zayed Federal Postgraduate Medical Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03593135.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing